Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified Health Condition 2: E789- Disorder of lipoprotein metabolism, unspecified Health Condition 3: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
None listed
Sponsors
All India Institute of Ayurveda, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group- age between 25 to 60 years of either gender 2. Newly diagnosed Patients or those who are not taking any anti-hyperlipidemic agents for more than 6 months. 3. Patients with any condition like TG grether than 150mg/dl, LDL-C greather than 100mg/dl, TC greather than 200mg/dl, HDL-C less than 40 mg/dl for men & less than 50mg/dl for women. [17] 4. Who are in the BMI range of normal weight (18.5 - 24.9) or the overweight category (25- 29.9). 5. Subject is ready to abide by the trial procedure & to give informed consent for the following dietary regimen and physical exercise advised.
Exclusion criteria
Exclusion criteria: 1. Patients with type 2 diabetes on insulin therapy and type 1 diabetes 2. Patients with hypothyroidism. 3. Coronary Heart disease patient with a previous history, bypass surgery or pacemaker, or stenting done 4. Pregnant & lactating mothers. 5. Who are doing regular exercises for more than 30 minutes consistently? 6. Patients with life-threatening disease and immunocompromised conditions 7. Patients who are not willing to limit alcohol consumption and quit smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average greater than 30% reduction in lipid levels from baseline to 6th week in both the group (trial group greater than control)Timepoint: Average greater than 30% reduction in lipid levels from baseline to 6th week in both the group (trial group greater than control) | — |
Secondary
| Measure | Time frame |
|---|---|
| Average change in the LFT and KFT baseline to 6th week in both the group (trial group greater than control), any serious adverse drug event throughout the study period in both the group (trial group greater than control) Timepoint: 6 weeks;Assessment of Quality of Life (QoL) among patients with dyslipidemia will be carried out using the SF-36 Health Survey. Timepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactShekhar Uike
All India Institute of Ayurveda, New Delhi
Outcome results
None listed